Publicacións nas que colabora con María Teresa Cabrera Castillo (16)

2011

  1. Leukocyte infiltrate in gastrointestinal adenocarcinomas is strongly associated with tumor microsatellite instability but not with tumor immunogenicity

    Cancer Immunology, Immunotherapy, Vol. 60, Núm. 6, pp. 869-882

2010

  1. Higher HLA class i expression in renal cell carcinoma than in autologous normal tissue

    Tissue Antigens, Vol. 75, Núm. 2, pp. 110-118

2005

  1. Analysis of NK cells and chemokine receptors in tumor infiltrating CD4 T lymphocytes in human renal carcinomas

    Cancer Immunology, Immunotherapy, Vol. 54, Núm. 9, pp. 858-866

2000

  1. Microsatellite instability analysis in tumors with different mechanisms for total loss of HLA expression

    Cancer Immunology Immunotherapy, Vol. 48, Núm. 12, pp. 684-690

1995

  1. DIFFERENT PATTERNS OF HLA‐DR ANTIGEN EXPRESSION IN NORMAL EPITHELIUM, HYPERPLASTIC AND NEOPLASTIC MALIGNANT LESIONS OF THE BREAST

    International Journal of Immunogenetics, Vol. 22, Núm. 4, pp. 299-310

1993

  1. HLA class I expression and HPV‐16 sequences in premalignant and malignant lesions of the cervix

    Tissue Antigens, Vol. 41, Núm. 2, pp. 65-71

  2. Natural history of HLA expression during tumour development

    Immunology Today

1992

  1. HLA molecules in basal cell carcinoma of the skin

    Immunobiology, Vol. 185, Núm. 5, pp. 440-452

1991

  1. Altered HLA Class I Expression in Non-Small Cell Lung Cancer Is Independent of c-myc Activation

    Cancer Research, Vol. 51, Núm. 9, pp. 2463-2468

  2. Can the HLA phenotype be used as a prognostic factor in breast carcinomas?

    International Journal of Cancer, Vol. 47, Núm. 6 S, pp. 146-154

  3. HLA Class I and II Expression in Rhabdomyosarcomas

    Immunobiology, Vol. 182, Núm. 5, pp. 440-448

  4. Loss of HLA Heavy Chain and β2‐Microglobulin in HLA Negative Tumours

    Scandinavian Journal of Immunology, Vol. 34, Núm. 2, pp. 147-152

  5. Molecular analysis of MHC‐class‐I alterations in human tumor cell lines

    International Journal of Cancer, Vol. 47, Núm. 6 S, pp. 123-130

  6. Tumor aggresiveness and MHC class I and II antigens in laryngeal and breast cancer

    Seminars in Cancer Biology, Vol. 2, Núm. 1, pp. 47-54

1990

  1. Presence of hpv 16 sequences in laryngeal carcinomas

    International Journal of Cancer, Vol. 46, Núm. 1, pp. 8-11

1989

  1. MHC CLASS I AND II ANTIGENS ON GASTRIC CARCINOMAS AND AUTOLOGOUS MUCOSA

    International Journal of Immunogenetics, Vol. 16, Núm. 4-5, pp. 413-423